Target intelligence / Profile preview

Copper homeostasis protein cutC homolog (CUTC)

Target
CUTC
Molecular classification
Copper-binding protein, Enzyme (cofactor: Cu(I)), Member of the Cut Copper Homeostasis (Cut) Family, Intracellular copper trafficking/metabolism protein
01

Overview

Copper homeostasis protein cutC homolog (CUTC) is a human intracellular protein of the Cut family, with a TIM-barrel fold and tetrameric structure that binds cuprous ion (Cu(I)) at a specific site involving conserved cysteine residues. Recent biochemical and structural analyses demonstrate that human CUTC does not function primarily as a membrane copper transporter; instead, it acts as a copper-binding enzyme, with Cu(I) serving as a cofactor. CUTC plays a role in copper homeostasis and intracellular trafficking/metabolism and may safeguard cells from copper-induced cytotoxicity, as silencing CUTC increases apoptotic effects in cells exposed to copper stress. The physiological functions remain incompletely defined, and disease associations have not been robustly characterized. There are currently no known drugs targeting CUTC directly, and its primary significance is in basic copper metabolism and cellular health, rather than as an established clinical therapeutic target.

Other names
cutC copper transportercopper homeostasis protein cutC homologCUTCCGI-32CutC protein, humancutC copper transporter homolog
02

Mechanism of action

Not established; no known drugs targeting CUTC

03

Biological functions

Copper binding and homeostasisIntracellular copper metabolism and traffickingPotential enzymatic activity using Cu(I) as cofactorCellular protection from copper-induced cytotoxicity
04

Disease associations

Possible role in copper-related metabolic disordersApoptosis induced by copper dysregulation (evidence from hCutC silencing)Other diseases associated with abnormal copper metabolism (uncertain direct link)
05

Safety considerations

Potential risk of copper toxicity/damage if CUTC is dysfunctional, leading to apoptosis and metabolic stressNo specific therapeutic safety concerns directly established (as CUTC is not currently a drug target)
06

Interacting drugs

None directly identified in current literature; no established clinical drugs that target CUTC specifically
07

Biomarkers

Increased cellular apoptosis and dysfunction when CUTC is silenced, in the context of copper-induced toxicityNo established clinical biomarker use

Beyond the preview

Go deeper on Copper homeostasis protein cutC homolog (CUTC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Copper homeostasis protein cutC homolog (CUTC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call